MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuo, M.-L.
Right arrow Articles by Chuang, S.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuo, M.-L.
Right arrow Articles by Chuang, S.-E.

Vol. 55, Issue 5, 894-901, May 1999

Suppression of Apoptosis by Bcl-2 to Enhance Benzene Metabolites-Induced Oxidative DNA Damage and Mutagenesis: A Possible Mechanism of Carcinogenesis

Min-Liang Kuo, Shine-Gwo Shiah, Chau-Jong Wang, and Shuang-En Chuang

Laboratory of Molecular & Cellular Toxicology, Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan (M.-L.K., S.-G.S.); Institute of Biochemistry, Chung-Shan Medical and Dental Collage (C.-J.W.); and Cancer Research Group, National Health Research Institutes (S.-E.C.), Taipei, Taiwan

Apoptosis plays a crucial role in maintaining genomic integrity by selectively removing the most heavily damaged cells from the population. Under that premise, the dysregulation of apoptosis may result in an inappropriate survival of mutated cells. This study demonstrates that ectopic expression of Bcl-2 effectively suppresses benzene-active metabolites, 1,4-hydroquinone- and 1,4-benzoquinone-induced apoptosis in human leukemic HL-60 cells, as evidenced by morphological changes and DNA fragmentation. Although reactive oxygen species production largely contributes to the benzene metabolites-induced apoptotic cell death, Bcl-2 fails to attenuate the benzene metabolites-elicited increase of reactive oxygen species in HL-60 cells, as confirmed by flow cytometry analysis. These data suggest that Bcl-2 prevents benzene metabolites-induced apoptosis at the downstream of oxidative damage events. This study also determines the level of 8-hydroxydeoxyguanosine (8-OH-dGua), an indicator for oxidative DNA damage, in neo- and Bcl-2-overexpressing HL-60 cells after treating with 1,4-hydroquinone or 1,4-benzoquinone. Interestingly, our results indicate that a majority of the 8-OH-dGua is efficiently removed in neo control cells within 3 to 6 h, whereas only 25 to 35% of 8-OH-dGua is repaired in Bcl-2 transfectants even for 24 h. Similarly, another oxidative DNA base, thymine glycol, failed to repair and was retained in genomic DNA of Bcl-2 transfectants. The above findings suggest that Bcl-2 may retain benzene metabolites-induced oxidative DNA damage in surviving cells. Indeed, the failure of repairing 8-OH-dGua and thymine glycol in benzene metabolites-treated Bcl-2 survivors increases the number of mutation frequencies at the hprt locus. Results in this study thus provide a novel benzene-induced carcinogenesis mechanism by which up-regulation of Bcl-2 protein may promote the susceptibility to benzene metabolites-induced mutagenesis by overriding apoptosis and attenuating DNA repair capacity.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Zhao, F. Gao, Y. Zhang, K. Wei, Y. Liu, and X. Deng
Bcl2 Inhibits Abasic Site Repair by Down-regulating APE1 Endonuclease Activity
J. Biol. Chem., April 11, 2008; 283(15): 9925 - 9932.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. G. Cox and M. B. Hampton
Bcl-2 over-expression promotes genomic instability by inhibiting apoptosis of cells exposed to hydrogen peroxide
Carcinogenesis, October 1, 2007; 28(10): 2166 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Hou, F. Gao, Q. Wang, J. Zhao, T. Flagg, Y. Zhang, and X. Deng
Bcl2 Impedes DNA Mismatch Repair by Directly Regulating the hMSH2-hMSH6 Heterodimeric Complex
J. Biol. Chem., March 23, 2007; 282(12): 9279 - 9287.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Jin, W. S. May, F. Gao, T. Flagg, and X. Deng
Bcl2 Suppresses DNA Repair by Enhancing c-Myc Transcriptional Activity
J. Biol. Chem., May 19, 2006; 281(20): 14446 - 14456.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Silva, A. L. Kovalchuk, J. S. Kim, G. Klein, and S. Janz
BCL2 Accelerates Inflammation-induced BALB/c Plasmacytomas and Promotes Novel Tumors with Coexisting T(12;15) and T(6;15) Translocations
Cancer Res., December 15, 2003; 63(24): 8656 - 8663.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Canitrot, R. Falinski, T. Louat, G. Laurent, C. Cazaux, J.-S. Hoffmann, D. Lautier, and T. Skorski
p210 BCR/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation
Blood, October 1, 2003; 102(7): 2632 - 2637.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. Bernstein, H. Holubec, J. A. Warneke, H. Garewal, D. L. Earnest, C. M. Payne, D. J. Roe, H. Cui, E. L. Jacobson, and C. Bernstein
Patchy Field Defects of Apoptosis Resistance and Dedifferentiation in Flat Mucosa of Colon Resections From Colon Cancer Patients
Ann. Surg. Oncol., June 1, 2002; 9(5): 505 - 517.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M.-T. Lin, C.-Y. Juan, K.-J. Chang, W.-J. Chen, and M.-L. Kuo
IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1
Carcinogenesis, December 1, 2001; 22(12): 1947 - 1953.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S.-G. Shiah, S.-E. Chuang, and M.-L. Kuo
Involvement of Asp-Glu-Val-Asp-Directed, Caspase-Mediated Mitogen-Activated Protein Kinase Kinase 1 Cleavage, c-Jun N-Terminal Kinase Activation, and Subsequent Bcl-2 Phosphorylation for Paclitaxel-Induced Apoptosis in HL-60 Cells
Mol. Pharmacol., February 1, 2001; 59(2): 254 - 262.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics